Dr. Cremona has received national and international recognition for her contributions to rare disease research, particularly in the field of alpha-1 antitrypsin deficiency. In 2022, she was awarded the ALTA Award, the most prestigious international honor dedicated to research on this condition. Building on this achievement, she has received multiple research grants over the years from Lungenliga Bern, Lungenliga Schweiz, and the Black Swan Foundation to further support her work on alpha-1 antitrypsin deficiency.

Beyond her scientific contributions, Dr. Cremona is highly active in the rare disease community, working closely with patient associations to increase awareness, promote education, and advocate for improved research and care.